BM
IPXL

Bridger Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Bridger Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-602,456
Closed -$12.2M – 41
2017
Q3 		$12.2M Sell
602,456
-738,687
-55% -$14.1M 0.73% 33
2017
Q2 		$21.6M Buy
+1,341,143
New +$19.8M 1.23% 32

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TG
TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bridger Management's IPXL Position: Q4 2017 in Review

Bridger Management sold out of Impax Laboratories, Inc. (IPXL) in Q4 2017, closing a stake of 602,456 shares — an estimated $12.2M sold.

Bridger Management first reported a position in IPXL in Q2 2017 and held it in 2 quarters. The position peaked at $21.6M in Q2 2017. 200 funds tracked by Wall St. Rank hold IPXL as of Q4 2017.

  • Bridger Management reported no remaining Impax Laboratories, Inc. position as of Q4 2017 after selling out during the quarter.
  • Bridger Management sold 602,456 Impax Laboratories, Inc. shares in Q4 2017, an estimated $12.2M.
  • Bridger Management first reported a position in Impax Laboratories, Inc. in Q2 2017 and held it in 2 quarters.
  • Bridger Management's Impax Laboratories, Inc. position peaked at $21.6M in Q2 2017.
  • 200 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2017.

Based on Bridger Management's 13F filing for Q4 2017, filed 14 Feb 2018.